|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.65 AUD | -0.76% |
|
-7.14% | -17.72% |
| Apr. 18 | Acusensus Files Infringement Proceedings Against One Task | MT |
| Feb. 26 | Acusensus Narrows Loss in Fiscal H1 Despite 25% Rise in Revenue; Shares Jump 4% | MT |
Acusensus Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 19.84 million compared to AUD 10.33 million a year ago. Net loss was AUD 0.262802 million compared to AUD 0.518828 million a year ago.
Basic loss per share from continuing operations was AUD 0.002 compared to AUD 0.006 a year ago. Diluted loss per share from continuing operations was AUD 0.002 compared to AUD 0.006 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.72% | 54.67M | |
| -4.87% | 195B | |
| +33.34% | 98.41B | |
| +58.20% | 65.76B | |
| +15.89% | 60.52B | |
| +31.42% | 32.45B | |
| +12.86% | 20.69B | |
| +51.63% | 18.63B | |
| -8.22% | 17.9B | |
| +17.50% | 11.26B |
ACUSENSUS LIMITED 
